G2E3-AS1: A Potential Drug Target and Biomarker (G105370431)

Target Name: G2E3-AS1

NCBI ID: G105370431

G2E3-AS1

Other Name(s): G2E3 antisense RNA 1 | CAT1647

G2E3-AS1: A Potential Drug Target and Biomarker

G2E3-AS1, also known as G2E3, is a non-coding RNA molecule that has been identified as an antisense RNA 1 in the G2E family of RNA molecules. The G2E family is characterized by the presence of a specific base-pairing pattern in the first exon region, which is conserved across various species. G2E3-AS1 is a 24.1-nanometer RNA molecule that consists of 191 amino acid residues.

G2E3-AS1 has been shown to play a critical role in various cellular processes, including cell signaling, gene regulation, and metabolism. One of the most significant functions of G2E3-AS1 is its role as an RNA regulators, where it interacts with multiple target RNAs to regulate their stability and translation efficiency.

G2E3-AS1 has been shown to regulate the stability of several target RNAs, including miR-18a, miR-202, and miR-204. These RNAs are involved in various cellular processes, including cell growth, apoptosis, and metabolism. By regulating the stability of these RNAs, G2E3-AS1 contributes to the regulation of cellular processes that are critical for human health and disease.

G2E3-AS1 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with several transcription factors, including nuclear factor E2 (NFE2), nuclear factor E1 (NFE1), and RNA polymerase II (RNA polymerase II). These transcription factors are involved in the regulation of various gene expression pathways that are involved in cellular processes, including cell growth, apoptosis, and metabolism.

G2E3-AS1 has been shown to be involved in the regulation of cellular signaling pathways. It has been shown to interact with several protein kinases, including casein kinase (CK) and Myosin kinase (MK). These protein kinases are involved in the regulation of various cellular signaling pathways, including cell growth, apoptosis, and metabolism.

G2E3-AS1 has also been shown to be involved in the regulation of cellular pathways that are involved in the development and progression of cancer. It has been shown to interact with several transcription factors, including T-cell factor (TCF), activating transcription factor 3 (ATF3), and p53. These transcription factors are involved in the regulation of various gene expression pathways that are involved in the development and progression of cancer.

G2E3-AS1 has been shown to play a role in the regulation of cellular pathways that are involved in the regulation of cellular memory and synaptosis. It has been shown to interact with several protein molecules, including neurotrophin (NT),CREB-interactive protein (CIP), and Calbindin. These protein molecules are involved in the regulation of various cellular processes, including the regulation of cellular memory and synaptosis.

G2E3-AS1 has also been shown to play a role in the regulation of cellular pathways that are involved in the regulation of cell cycle progression. It has been shown to interact with several transcription factors, including cyclin D1 (CDK1), cyclin D3 (CDK3), and p21. These transcription factors are involved in the regulation of various cellular processes, including cell cycle progression.

G2E3-AS1 has been shown to play a role in the regulation of cellular pathways that are involved in the regulation of cellular apoptosis. It has been shown to interact with several transcription factors, including activating transcription factor 6 (ATF6), and p53. These transcription factors are involved in the regulation of various cellular processes, including cell apoptosis.

G2E3-AS1 has also been shown to play a role in the regulation of cellular pathways that are involved in the regulation of cellular signaling pathways. It has been shown to interact with several transcription factors, including NF-kappa-B signaling pathway,

Protein Name: G2E3 Antisense RNA 1

The "G2E3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about G2E3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets